Chabiotech Co.,Ltd.
Develops cell/gene therapies and provides CDMO and bio-banking services.
085660 | KO
Overview
Corporate Details
- ISIN(s):
- KR7085660009
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 도산대로 442 청담동 피엔폴루스 3층, 강남구
- Website:
- http://en.chabio.com/
Description
Chabiotech Co., Ltd. is a biotechnology company specializing in the research and development of cell and gene therapies for rare cancers and incurable diseases. The company's core activities include advancing its therapeutic pipelines and providing global Contract Development and Manufacturing Organization (CDMO) services for advanced biopharmaceuticals, including full-scale GMP production and testing. Chabiotech also operates bio-banking services, such as cord blood and immune/stem cell storage, utilizing advanced cryopreservation technology. Its diversified business segments extend to genomics for precision medicine, healthcare IT solutions that integrate AI and Big Data, comprehensive wellness programs, and specialized healthcare consulting.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-04-12 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 26.0 KB | ||
| 2023-04-12 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 195.2 KB | ||
| 2023-04-07 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 184.5 KB | ||
| 2023-03-31 00:00 |
정기주주총회결과
|
Korean | 23.7 KB | ||
| 2023-03-31 00:00 |
대표이사변경
|
Korean | 13.2 KB | ||
| 2023-03-31 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 22.8 KB | ||
| 2023-03-22 00:00 |
감사보고서제출
|
Korean | 25.4 KB | ||
| 2023-03-22 00:00 |
사업보고서 (2022.12)
|
Korean | 3.5 MB | ||
| 2023-03-16 00:00 |
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 23.8 KB | ||
| 2023-03-16 00:00 |
주주총회소집결의
|
Korean | 12.6 KB | ||
| 2023-03-16 00:00 |
주주총회집중일개최사유신고
|
Korean | 5.0 KB | ||
| 2023-03-16 00:00 |
주주총회소집공고
|
Korean | 2.2 MB | ||
| 2023-03-16 00:00 |
의결권대리행사권유참고서류
|
Korean | 2.2 MB | ||
| 2023-03-02 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 14.0 KB | ||
| 2023-03-02 00:00 |
투자판단관련주요경영사항(AMD(노인성 황반변성) 치료제 국내 임상 1/2a상 조기 종료)
|
Korean | 6.9 KB |
Automate Your Workflow. Get a real-time feed of all Chabiotech Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Chabiotech Co.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Chabiotech Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
